A pioneering food additive that can stop people from gaining weight has appeared on the EU's Novel Food List, indicating its safety for human consumers. Inulin propionate ester, or IPE, is a dietary fiber developed and tested ...
Jul 2, 2026
0
100
The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) to delay the decline in endogenous insulin production in children aged 8 to 17 years recently diagnosed with stage ...
Jul 2, 2026
0
3
For adults with type 2 diabetes mellitus (T2DM), bofanglutide, a glucagon-like peptide-1 receptor agonist, is associated with more meaningful reductions in hemoglobin A1C (HbA1c) levels than semaglutide, according to a study ...
Jul 2, 2026
0
5
For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other ...
Jul 2, 2026
0
13
Researchers are calling for hearing tests to become a standard part of diabetes care and for hearing loss to be recognized as a significant complication of the condition. Dr. Mehwish Nisar from UQ's School of Public Health ...
Jul 2, 2026
0
4
Patients experiencing life-threatening diabetic ketoacidosis (DKA) require quick action, diligent care and close monitoring as they receive insulin infusions and other medical interventions to bring their blood glucose and ...
Jul 2, 2026
0
2
Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure. These risks are significantly exacerbated if a type 2 diabetes diagnosis is ...
Jul 1, 2026
0
6
If you're 18, getting a bit more sleep could matter more than you think. New research from the University of Copenhagen and COPSAC shows that even in healthy young people, longer nights of sleep are linked to more stable ...
Jul 1, 2026
0
4
According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications reduce the number of deaths, amputations and hospitalizations among people with ...
Jul 1, 2026
0
5
A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogs in low-resource ...
Jun 30, 2026
0
5
